Log In
Print this Print this

Lymfactin (AdVEGF-C)

  Manage Alerts
Collapse Summary General Information
Company Herantis Pharma plc
DescriptionAdenoviral vector expressing VEGF-C
Molecular Target Vascular endothelial growth factor C (VEGF-C)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat secondary lymphedema
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today